Overview

A PK Study Comparing VeraCept vs. ParaGard Intrauterine Devices (IUDs)

Status:
Active, not recruiting
Trial end date:
2024-12-30
Target enrollment:
Participant gender:
Summary
to Assess the Pharmacokinetic Properties of VeraCept™ Intrauterine Contraceptive vs ParaGard® in Healthy, Post- Menarcheal Women
Phase:
Phase 3
Details
Lead Sponsor:
Sebela Pharmaceuticals Inc.
Collaborator:
Synteract, Inc.